greeksoup/ stocks
Stocks / United States / VRTX / Insiders

Vertex Pharmaceuticals Inc. / MA insider trading

In the last twelve months insiders at Vertex Pharmaceuticals Inc. / MA filed 55 open-market sales worth $71.9 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Tatsis Ourania, EVP, Chief Reg. & Quality Off., sold 1,500 shares at $524.99 on 2 July 2026, filed 7 July 2026.

TradedInsiderRoleTypeSharesPriceValueFiling
2 July 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sale1,500$524.99$787,485Form 4
2 July 2026Mckechnie DuncanEVP, Chief Commercial OfficerSale1,541$519.00$799,779Form 4
1 July 2026Liu JoyEVP and Chief Legal OfficerSale828$502.71$416,244Form 4
26 June 2026Bozic CarmenEVP and CMOSale596$482.50$287,570Form 4
18 June 2026Bozic CarmenEVP and CMOSale1,020$462.17$471,413Form 4
15 June 2026Bozic CarmenEVP and CMOSale4,062$450.00$1.8 millionForm 4
5 June 2026Bozic CarmenEVP and CMOSale1,745$450.00$785,250Form 4
1 June 2026Liu JoyEVP and Chief Legal OfficerSale828$439.91$364,245Form 4
29 May 2026Bozic CarmenEVP and CMOSale1,974$450.00$888,300Form 4
15 May 2026Bunnage Mark E.EVP, Chief Scientific OfficerSale33$453.45$14,964Form 4
15 May 2026Bozic CarmenEVP and CMOSale1,354$453.45$613,971Form 4
12 May 2026Bozic CarmenEVP and CMOSale6,988$450.00$3.1 millionForm 4
4 May 2026Bhatia Sangeeta N.DirectorSale318$423.73$134,746Form 4
1 May 2026Liu JoyEVP and Chief Legal OfficerSale1,104$425.02$469,222Form 4
1 April 2026Liu JoyEVP and Chief Legal OfficerSale978$449.17$439,288Form 4
27 March 2026Bozic CarmenEVP and CMOSale2,329$450.95$1.1 millionForm 4
13 March 2026Bozic CarmenEVP and CMOSale2,329$481.79$1.1 millionForm 4
11 March 2026Mckechnie DuncanEVP, Chief Commercial OfficerSale2,633$498.42$1.3 millionForm 4
4 March 2026Mckechnie DuncanEVP, Chief Commercial OfficerSale2,437$475.30$1.2 millionForm 4
2 March 2026Liu JoyEVP and Chief Legal OfficerSale892$495.96$442,396Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale400$479.75$191,900Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale120$481.50$57,780Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale240$482.84$115,882Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale2,510$487.13$1.2 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale3,278$488.27$1.6 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale460$489.32$225,087Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale2,725$490.54$1.3 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale949$491.30$466,244Form 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale2,520$493.29$1.2 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale3,498$494.33$1.7 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale15,580$495.38$7.7 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale5,995$496.16$3.0 millionForm 4
27 February 2026Kewalramani ReshmaCEO & PresidentSale1,725$496.95$857,239Form 4
27 February 2026Bozic CarmenEVP and CMOSale2,329$480.31$1.1 millionForm 4
26 February 2026Ambrose KristenSVP & Chief Accounting OfficerSale357$483.36$172,560Form 4
25 February 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sale260$486.35$126,451Form 4
25 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale1,846$486.35$897,802Form 4
25 February 2026Mckechnie DuncanEVP, Chief Commercial OfficerSale2,500$486.35$1.2 millionForm 4
25 February 2026Mckechnie DuncanEVP, Chief Commercial OfficerSale2,410$489.00$1.2 millionForm 4
25 February 2026Bunnage Mark E.EVP, Chief Scientific OfficerSale620$486.35$301,537Form 4
25 February 2026Biller JonathanEVP and Chief Legal OfficerSale945$486.35$459,601Form 4
25 February 2026Atkinson Edward Morrow IiiEVP, Chief Technical Ops. Off.Sale668$486.35$324,882Form 4
25 February 2026Ambrose KristenSVP & Chief Accounting OfficerSale223$486.35$108,456Form 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale920$463.91$426,797Form 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale2,730$465.05$1.3 millionForm 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale1,848$465.80$860,798Form 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale10,263$467.75$4.8 millionForm 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale19,662$468.57$9.2 millionForm 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale7,241$469.61$3.4 millionForm 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale11,712$470.54$5.5 millionForm 4
19 February 2026Sachdev AmitEVP Chief Patient & Ext Af OffSale4,237$471.43$2.0 millionForm 4
18 February 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sale368$473.68$174,314Form 4
18 February 2026Bunnage Mark E.EVP, Chief Scientific OfficerSale1,182$473.68$559,890Form 4
17 February 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.Sale609$489.46$298,081Form 4
17 February 2026Bunnage Mark E.EVP, Chief Scientific OfficerSale2,437$489.46$1.2 millionForm 4

Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.

Source

Form 4 filings on EDGAR for Vertex Pharmaceuticals Inc. / MA: the company's filing index.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install